Logo image of TRUG

TRUGOLF HOLDINGS INC (TRUG) Stock Fundamental Analysis

NASDAQ:TRUG - Nasdaq - US2437331026 - Common Stock - Currency: USD

0.215  -0.01 (-5.33%)

After market: 0.216 +0 (+0.47%)

Fundamental Rating

1

TRUG gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 71 industry peers in the Entertainment industry. TRUG has a bad profitability rating. Also its financial health evaluation is rather negative. TRUG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TRUG had negative earnings in the past year.
TRUG had a negative operating cash flow in the past year.
TRUG Yearly Net Income VS EBIT VS OCF VS FCFTRUG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

With a Return On Assets value of -51.31%, TRUG is not doing good in the industry: 85.92% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -51.31%
ROE N/A
ROIC N/A
ROA(3y)-18.57%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRUG Yearly ROA, ROE, ROICTRUG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 400 600

1.3 Margins

TRUG has a better Gross Margin (63.50%) than 73.24% of its industry peers.
TRUG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TRUG Yearly Profit, Operating, Gross MarginsTRUG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

0

2. Health

2.1 Basic Checks

TRUG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TRUG has been increased compared to 1 year ago.
Compared to 1 year ago, TRUG has a worse debt to assets ratio.
TRUG Yearly Shares OutstandingTRUG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
TRUG Yearly Total Debt VS Total AssetsTRUG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -0.75, we must say that TRUG is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of TRUG (-0.75) is worse than 74.65% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.75
ROIC/WACCN/A
WACC12.27%
TRUG Yearly LT Debt VS Equity VS FCFTRUG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

TRUG has a Current Ratio of 0.94. This is a bad value and indicates that TRUG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of TRUG (0.94) is comparable to the rest of the industry.
A Quick Ratio of 0.79 indicates that TRUG may have some problems paying its short term obligations.
TRUG has a Quick ratio of 0.79. This is comparable to the rest of the industry: TRUG outperforms 46.48% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.79
TRUG Yearly Current Assets VS Current LiabilitesTRUG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

TRUG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -80.82%.
EPS 1Y (TTM)-80.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-392.37%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

TRUG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.70% yearly.
Based on estimates for the next years, TRUG will show a very strong growth in Revenue. The Revenue will grow by 30.49% on average per year.
EPS Next Y72.22%
EPS Next 2Y56.35%
EPS Next 3Y47.7%
EPS Next 5YN/A
Revenue Next Year18.13%
Revenue Next 2Y24.71%
Revenue Next 3Y30.49%
Revenue Next 5YN/A

3.3 Evolution

TRUG Yearly Revenue VS EstimatesTRUG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 10M 20M 30M 40M 50M
TRUG Yearly EPS VS EstimatesTRUG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 0.2 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TRUG. In the last year negative earnings were reported.
Also next year TRUG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TRUG Price Earnings VS Forward Price EarningsTRUG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRUG Per share dataTRUG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

4.3 Compensation for Growth

TRUG's earnings are expected to grow with 47.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.35%
EPS Next 3Y47.7%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TRUG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRUGOLF HOLDINGS INC

NASDAQ:TRUG (5/20/2025, 8:00:01 PM)

After market: 0.216 +0 (+0.47%)

0.215

-0.01 (-5.33%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)04-15 2025-04-15/amc
Earnings (Next)N/A N/A
Inst Owners1.09%
Inst Owner ChangeN/A
Ins Owners17.01%
Ins Owner Change109.13%
Market Cap6.42M
Analysts85
Price Target1.91 (788.37%)
Short Float %3.12%
Short Ratio0.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-50%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.54%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0.73
BVpS-0.16
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.5%
FCFM N/A
ROA(3y)-18.57%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 271.62%
Cap/Sales 7.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.79
Altman-Z -0.75
F-Score2
WACC12.27%
ROIC/WACCN/A
Cap/Depr(3y)108.54%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-80.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-392.37%
EPS Next Y72.22%
EPS Next 2Y56.35%
EPS Next 3Y47.7%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year18.13%
Revenue Next 2Y24.71%
Revenue Next 3Y30.49%
Revenue Next 5YN/A
EBIT growth 1Y-9.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year525.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-453.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-285.53%
OCF growth 3YN/A
OCF growth 5YN/A